Company news

ASKA Pharmaceutical Holdings Co., Ltd. news in 2024

ASKA Pharmaceutical Holdings Co., Ltd.'s news releases, calls and decks from 2024, newest first.

View company

May 31 2024 Licensing Agreement for Relugolix Combination Tablet for Endometriosis in the Gynecologic Disease Area

May 31, 2024

April 25 2024 Personnel Changes of ASKA Pharmaceutical Holdings' Subsidiaries

April 25, 2024

ASKA Pharmaceutical Holdings: March 26 2024 ASKA Pharmaceutical Receives Approval for Partial Change of Manufacturing and Marketing Approval for RIFXIMA® TABLETS for Pediatric Indication

March 26, 2024

Decks in 2024